Volume 179, Issue 12 (Dec-22)
EDITOR’S NOTE
1. New Therapeutic Approaches Involving Psychopharmacology, Digital Technology, and fMRI Neurofeedback
- Ned H. Kalin, M.D.
- Pages:881–885
- PDF
EDITORIALS
2. Naltrexone and Alcohol Use
- Jonathan Avery, M.D.
- Pages:886–887
- PDF
3. Neurofeedback for ADHD: Time to Call It Quits?
- James J. McGough, M.D., M.S.
- Pages:888–889
- PDF
4. An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression
- Alan F. Schatzberg, M.D.
- Pages:890–891
- PDF
CLINICAL CASE CONFERENCE
5. A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability
- Gregory Barber, M.D., Charles B. Nemeroff, M.D., Ph.D., Steven Siegel, M.D., Ph.D.
- Pages:892–896
- PDF
REVIEWS AND OVERVIEWS
6. Technology and Mental Health: State of the Art for Assessment and Treatment
- Philip D. Harvey, Ph.D., Colin A. Depp, Ph.D., Albert A. Rizzo, Ph.D., Gregory P. Strauss, Ph.D., David Spelber, M.D., Linda L. Carpenter, M.D., Ned H. Kalin, M.D., John H. Krystal, M.D., William M. McDonald, M.D., … See all authors
- Pages:897–914
- PDF
ARTICLES
7. Targeted Oral Naltrexone for Mild to Moderate Alcohol Use Disorder Among Sexual and Gender Minority Men: A Randomized Trial
- Glenn-Milo Santos, Ph.D., M.P.H., Janet Ikeda, M.A., Phillip Coffin, M.D., M.I.A., John Walker, N.P., Tim Matheson, Ph.D., Arsheen Ali, B.A., Matthew McLaughlin, A.B., Jennifer Jain, Ph.D., M.P.H., Justine Arenander, M.S.W., … See all authors
- Pages:915–926
- PDF
8. Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial
- Carlos M. Grilo, Ph.D., Janet A. Lydecker, Ph.D., Sarah K. Fineberg, M.D., Ph.D., Jorge O. Moreno, M.D., Valentina Ivezaj, Ph.D., Ralitza Gueorguieva, Ph.D.
- Pages:927–937
- PDF
9. Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis
- Marco Solmi, M.D., Ph.D., Heidi Taipale, Ph.D., Minna Holm, Ph.D., Antti Tanskanen, Ph.D., Ellenor Mittendorfer-Rutz, Ph.D., Christoph U. Correll, M.D., Ph.D., Jari Tiihonen, M.D., Ph.D.
- Pages:938–946
- PDF
10. Double-Blind, Sham-Controlled Randomized Trial Testing the Efficacy of fMRI Neurofeedback on Clinical and Cognitive Measures in Children With ADHD
- Sheut-Ling Lam, Ph.D., Marion Criaud, Ph.D., Steve Lukito, Ph.D., Samuel J. Westwood, Ph.D., Deborah Agbedjro, Ph.D., Olivia S. Kowalczyk, Ph.D., Sarah Curran, M.D., Ph.D., Nadia Barret, M.D., Chris Abbott, M.D., … See all authors
- Pages:947–958
- PDF
11. A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial
- Rebecca B. Price, Ph.D., Crystal Spotts, M.Ed., Benjamin Panny, B.S., Angela Griffo, B.S., Michelle Degutis, M.S., Nicolas Cruz, M.Ed., Elizabeth Bell, B.S., Kevin Do-Nguyen, B.S., Meredith L. Wallace, Ph.D., … See all authors
- Pages:959–968
- PDF
RESIDENTS’ JOURNAL
12. Highlights From the Residents’ Journal: September 2022
APPRECIATION
13. Reviewers for The American Journal of Psychiatry
OTHER ITEMS OF INTEREST
14. Correction